Sh-oligopeptide-5 (inci)

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

SH-oligopeptide-5 ("sh" is the acronym for "synthetic and human") is a recombinant, synthetic, human oligopeptide. "Oligopeptide" generally refers to a linear peptide chain of up to 10 amino acids (usually alpha-amino acids) linked together by peptide bonds (amide bonds).

Note(s)This section has been translated automatically.

SH-oligopeptide-5 refers to the synthetic oligopeptide-5 produced by genetically manipulated E. coli strains using bioengineering technologies. The starter gene is an exact synthetic copy of the human gene coding for "ARS interacting multi-functional protein 1" (AIMP1). ARS-interacting multi-functional protein 1 is a cytokine involved in the regulation of angiogenesis, immune activation and proliferation of fibroblasts.

SH-oligopeptide-5 is used in cosmetic formulations. The peptide mixture acts as a skin protection agent (protects the skin from external influences).

LiteratureThis section has been translated automatically.

  1. Kim SY et al (2013) ARS interacting multi-functional protein 1 induces proliferation of human bone marrow-derived mesenchymal stem cells by accumulation of β-catenin via fibroblast growth factor receptor 2-mediated activation of Akt. Stem Cells Dev 22: 2630-2640. https://www.ncbi.nlm.nih.gov/pubmed/23672191

Authors

Last updated on: 29.10.2020